Picture Kentro Design Corporate and Web Design Berlin 650x65px
Organisation › Details

Inivata Ltd.

Inivata is a leader in liquid biopsy. Its InVision® platform unlocks essential genomic information from a simple blood test to transform the care of cancer patients. The Company’s technology is based on pioneering research from the Cancer Research UK Cambridge Institute, University of Cambridge and reinforced by multiple high calibre publications. Its lead product, InVisionFirst™-Lung, is commercially available and provides molecular insights that enable clinicians to make more informed treatment decisions for NSCLC patients. Inivata is partnering with pharmaceutical and biotechnology companies on InVisionFirst™-Lung and its wider platform, which is applicable to a range of cancer types. The Company has a CLIA laboratory in Research Triangle Park, NC and laboratories in Cambridge, UK. *


Period Start 2014-09-01 splitoff
Products Industry cancer test, molecular diagnostics
  Industry 2 circulating tumor cell technology (CTC technology)
Persons Person Stocum, Michael (Inivata 201603 CEO)
  Person 2 Rosenfeld, Nitzan (Inivata 201603 CSO)
Region Region Cambridge, Cambridgeshire
  Country United Kingdom (GB)
  Street The Portway Building
Granta Park
  City CB21 6GS Cambridge, Cambridgeshire
  Tel +44-1223-790880
    Address record changed: 2019-03-31
Basic data Employees n. a.
    * Document for �About Section�: Inivata Ltd.. (3/28/19). "Press Release: Inivata Completes $52.6m (£39.8m) Series B Funding Round". Research Triangle Park, NC & Cambridge.
Record changed: 2020-01-11


Picture [LSUS] – The Business Web Portal 650x65px

More documents for Inivata Ltd.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSA] – The Business Web Portal 650x89px

» top